Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

37.5%

3 terminated/withdrawn out of 8 trials

Success Rate

57.1%

-29.4% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

125%

5 of 4 completed trials have results

Key Signals

1 recruiting5 with results

Enrollment Performance

Analytics

N/A

4(50.0%)

Phase 2

2(25.0%)

Phase 3

1(12.5%)

Phase 4

1(12.5%)

8Total

N/A(4)

Phase 2(2)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04787471Phase 2Recruiting

Corneal Crosslinking for Treatment of Corneal Neovascularization

Role: collaborator

NCT03248037Phase 3Completed

Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation

Role: lead

NCT04018417Phase 2Withdrawn

Evaluation of Amphotericin B in Optisol-GS for Prevention of Post-Keratoplasty Fungal Infections.

Role: lead

NCT00800111Not ApplicableCompleted

Study of Endothelial Keratoplasty Outcomes

Role: lead

NCT00884039Not ApplicableTerminated

Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients

Role: lead

NCT00912509Not ApplicableTerminated

Cross Linking for Treatment of Corneal Infection

Role: collaborator

NCT00624221Not ApplicableCompleted

Study of Eye Bank Pre-cut Donor Grafts for Endothelial Keratoplasty

Role: lead

NCT01853696Phase 4Completed

Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty

Role: lead

All 8 trials loaded